High Sierra Technologies Inc
High Sierra Technologies Inc operates in the drug retailing industry, providing pharmaceutical and consumer health products to customers.
Business. High Sierra Technologies Inc (HSTI.PK) operates in the Drug Retailers industry within the Consumer Non-Cyclicals sector. The company is headquartered in the United States and is listed on the OTC market. Specific details regarding operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
High Sierra Technologies Inc (HSTI.PK) operates in the Drug Retailers industry within the Consumer Non-Cyclicals sector. The company is headquartered in the United States and is listed on the OTC market. Specific details regarding operating segments and geographic revenue mix are not available.
High Sierra Technologies Inc has a negative equity position of -$436,270 million, indicating a significant financial distress with total liabilities of $584,670 million and total assets of $148,410 million. The company's liquidity is further strained by a current ratio of 0.12, suggesting a high risk of short-term insolvency. The negative operating cash flow of -$176,520 million and free cash flow of -$25,700 million indicate a lack of cash generation from operations.
The company's profitability is severely negative, with a net income of -$34,540 million and an operating income of -$19,020 million. The return on equity of 7.92% is misleading due to the negative equity base, and the return on assets of -23.27% indicates a poor use of assets to generate profit. These metrics are far below the industry medians for profitability and returns, suggesting a significant underperformance relative to peers.
The company's revenue is reported as $0 million, indicating a lack of disclosed revenue streams or operational activity. There is no information provided on geographic exposure or segment performance, making it difficult to assess revenue concentration or diversification.
The company's growth trajectory is unclear due to the absence of revenue data and the negative financial performance. The outlook for the current and next fiscal years is not provided, but the negative operating and net income suggest a challenging environment for growth.
The company faces significant liquidity and solvency risks, with a negative net cash position after subtracting total debt. The dilution risk is currently low, but the negative equity and high debt levels could lead to future dilution if the company requires additional capital. The adjustments applied in the valuation reflect the company's financial distress and the potential for further dilution.
There are no recent events or filings provided that would indicate significant changes in the company's operations or financial status. The lack of disclosed revenue and the negative financial performance suggest a need for further investigation into the company's business model and financial health.
- High Sierra Technologies Inc is in a severe financial distress with negative equity and high liabilities.
- The company's profitability is extremely poor, with significant negative net and operating income.
- There is no disclosed revenue, indicating a lack of operational activity or financial transparency.
- The company's liquidity and solvency risks are high, with a negative net cash position and a low current ratio.
- The outlook for growth is uncertain due to the absence of revenue data and negative financial performance.
- The company's risk profile is dominated by liquidity and solvency concerns, with potential for future dilution.
Bull / Bear case
Generated · model-assistedThe company's cash conversion metric of 5.11 ranks above the 75th percentile within its peer group of 29 companies.
Operating income improved by 6.9% year-over-year in the latest fiscal period, indicating a slight operational recovery trend.
Net income losses narrowed by 2.4% year-over-year in the most recent fiscal year compared to the prior period.
The debt-to-equity ratio is classified as best-in-class relative to the Drug Retailers cohort median of 0.38.
The company carries a high credit risk flag, reflecting significant concerns regarding its ability to meet financial obligations.
High Sierra Technologies reported zero revenue across all five analyzed fiscal periods, indicating a lack of core business income.
A current ratio of 0.0889 indicates severe liquidity constraints, as current assets cover less than 9% of current liabilities.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- High Sierra Technologies Inc Market data — financials · 2026-05-28
Ownership & reference
Leadership
- Vincent LombardiPresident, Chief Executive Officer, Director
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Total liabilities (YoY) (2022-12-31 vs 2021-12-31): 4.6%Derived (calculated)
- Shareholders' equity (YoY) (2022-12-31 vs 2021-12-31): -17.0%Derived (calculated)
- Total assets (YoY) (2022-12-31 vs 2021-12-31): -31.6%Derived (calculated)
- EPS (diluted) (YoY) (2022-12-31 vs 2021-12-31): 50.0%Derived (calculated)
- EPS (basic) (YoY) (2022-12-31 vs 2021-12-31): 50.0%Derived (calculated)
- Return on equity (FY 2022-12-31): 63.5%Derived (calculated)
- Return on assets (FY 2022-12-31): -319.2%Derived (calculated)
- Current ratio (FY 2022-12-31): 0.04xDerived (calculated)
- Debt-to-equity (FY 2022-12-31): -1.20xDerived (calculated)
- Net income (YoY) (2022-12-31 vs 2021-12-31): -2.4%Derived (calculated)
- Operating cash flow (YoY) (2022-12-31 vs 2021-12-31): -24.4%Derived (calculated)
- Operating income (YoY) (2022-12-31 vs 2021-12-31): 6.9%Derived (calculated)
- Operating cash flow (annual): USD -219.66KSEC XBRL filing
- Total liabilities (annual): USD 611.78KSEC XBRL filing
- Pre-tax income (annual): USD -323.95KSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
- Total assets (annual): USD 101.5KSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing
- Shares outstanding (annual): 20.62MSEC XBRL filing
- Interest expense (annual): USD 66.47KSEC XBRL filing
- Capex (annual): USD 43.44KSEC XBRL filing
- Current liabilities (annual): USD 561.78KSEC XBRL filing
- Shareholders' equity (annual): USD -510.28KSEC XBRL filing
- Net income (annual): USD -323.95KSEC XBRL filing